PDF(Pubmed)
Abstract：
UNASSIGNED: Dizziness is a growing public health concern with as many as 95 million adults in Europe and the United States experiencing vestibular hypofunction, which is associated with reduced quality of life, poorer health, and falls. Vestibular rehabilitation therapy (VRT) is effective in reducing symptoms and improving balance; however, limited access to qualified clinicians and poor patient adherence impedes optimal delivery. The goal of this study was to develop and evaluate the feasibility of a remote therapeutic monitoring VRT Platform application (APP) for the assessment and treatment of vestibular dysfunction.
UNASSIGNED: User-centered iterative design process was used to gather and integrate the needs of users (clinicians and patients) into the design at each stage of development. Commonly used vestibular patient-reported outcome measures (PROs) were integrated into the APP and adults with chronic dizziness were enrolled to evaluate validity and reliability of the APP compared to standard clinical measures (CLIN). Gaze stabilization exercises were gamified to provide an engaging experience and an off-the-shelf sensor captured eye and head movement to provide feedback on accuracy of performance. A prospective, pilot study design with pre-and post-treatment assessment assessed feasibility of the APP compared to standard VRT (CLIN).
UNASSIGNED: Participants with dizziness wanted a summary rehabilitation report shared with their clinicians, felt that an app could help with accountability, and believed that a gaming format might help with exercise adherence. Clinicians felt that the app should include features to record and track eye and head movement, monitor symptoms, score accuracy of task performance, and measure adherence. Validity and reliability of the digital PROs (APP) were compared to scores from CLIN across two sessions and found to have good validity, good to excellent test-retest reliability, and excellent usability (≥88%ile). The pilot study demonstrated feasibility for use of the APP compared to CLIN for treatment of vestibular hypofunction. The mean standard system usability score of the APP was 82.5 indicating excellent usability.
UNASSIGNED: Both adult patients with chronic dizziness and VRT clinicians were receptive to the use of technology for VRT. The HiM-V APP is a feasible alternative to clinical management of adults with chronic peripheral vestibular hypofunction.
UNASSIGNED: User-centered iterative design process was used to gather and integrate the needs of users (clinicians and patients) into the design at each stage of development. Commonly used vestibular patient-reported outcome measures (PROs) were integrated into the APP and adults with chronic dizziness were enrolled to evaluate validity and reliability of the APP compared to standard clinical measures (CLIN). Gaze stabilization exercises were gamified to provide an engaging experience and an off-the-shelf sensor captured eye and head movement to provide feedback on accuracy of performance. A prospective, pilot study design with pre-and post-treatment assessment assessed feasibility of the APP compared to standard VRT (CLIN).
UNASSIGNED: Participants with dizziness wanted a summary rehabilitation report shared with their clinicians, felt that an app could help with accountability, and believed that a gaming format might help with exercise adherence. Clinicians felt that the app should include features to record and track eye and head movement, monitor symptoms, score accuracy of task performance, and measure adherence. Validity and reliability of the digital PROs (APP) were compared to scores from CLIN across two sessions and found to have good validity, good to excellent test-retest reliability, and excellent usability (≥88%ile). The pilot study demonstrated feasibility for use of the APP compared to CLIN for treatment of vestibular hypofunction. The mean standard system usability score of the APP was 82.5 indicating excellent usability.
UNASSIGNED: Both adult patients with chronic dizziness and VRT clinicians were receptive to the use of technology for VRT. The HiM-V APP is a feasible alternative to clinical management of adults with chronic peripheral vestibular hypofunction.
摘要：
头晕是一个日益严重的公共卫生问题，在欧洲和美国，多达9500万成年人正在经历前庭功能减退，这与生活质量下降有关，健康状况较差,和瀑布。前庭康复治疗（VRT）可有效减轻症状并改善平衡；但是，获得合格临床医生的机会有限和患者依从性差阻碍了最佳分娩。这项研究的目的是开发和评估远程治疗监测VRT平台应用程序（APP）用于评估和治疗前庭功能障碍的可行性。
■以用户为中心的迭代设计过程用于收集用户（临床医生和患者）的需求并将其整合到每个开发阶段的设计中。将常用的前庭患者报告的结果指标（PRO）整合到APP中，并招募了患有慢性头晕的成年人，以评估APP与标准临床指标（CLIN）相比的有效性和可靠性。凝视稳定练习被游戏化，以提供引人入胜的体验，并通过现成的传感器捕获眼睛和头部的运动，以提供有关性能准确性的反馈。一个潜在的，与标准VRT（CLIN）相比，通过治疗前和治疗后评估评估了APP的可行性。
■患有头晕的参与者希望与临床医生分享总结康复报告，觉得一个应用程序可以帮助问责，并认为游戏形式可能有助于锻炼依从性。临床医生认为该应用程序应包括记录和跟踪眼睛和头部运动的功能，监测症状，任务绩效的得分准确性，并衡量坚持。将数字PRO（APP）的有效性和可靠性与CLIN在两个会话中的得分进行了比较，发现具有良好的有效性，良好的重测可靠性，和出色的可用性（≥88%ile）。初步研究证明了与CLIN相比，APP用于治疗前庭功能减退的可行性。APP的平均标准系统可用性得分为82.5，表明具有出色的可用性。
■患有慢性头晕的成年患者和VRT临床医生都接受VRT技术的使用。HiM-VAPP是对患有慢性外周前庭功能减退的成人进行临床治疗的可行替代方案。
■以用户为中心的迭代设计过程用于收集用户（临床医生和患者）的需求并将其整合到每个开发阶段的设计中。将常用的前庭患者报告的结果指标（PRO）整合到APP中，并招募了患有慢性头晕的成年人，以评估APP与标准临床指标（CLIN）相比的有效性和可靠性。凝视稳定练习被游戏化，以提供引人入胜的体验，并通过现成的传感器捕获眼睛和头部的运动，以提供有关性能准确性的反馈。一个潜在的，与标准VRT（CLIN）相比，通过治疗前和治疗后评估评估了APP的可行性。
■患有头晕的参与者希望与临床医生分享总结康复报告，觉得一个应用程序可以帮助问责，并认为游戏形式可能有助于锻炼依从性。临床医生认为该应用程序应包括记录和跟踪眼睛和头部运动的功能，监测症状，任务绩效的得分准确性，并衡量坚持。将数字PRO（APP）的有效性和可靠性与CLIN在两个会话中的得分进行了比较，发现具有良好的有效性，良好的重测可靠性，和出色的可用性（≥88%ile）。初步研究证明了与CLIN相比，APP用于治疗前庭功能减退的可行性。APP的平均标准系统可用性得分为82.5，表明具有出色的可用性。
■患有慢性头晕的成年患者和VRT临床医生都接受VRT技术的使用。HiM-VAPP是对患有慢性外周前庭功能减退的成人进行临床治疗的可行替代方案。
